IBBR Publications

Found 29 results
Filters: Keyword is Surface Plasmon Resonance  [Clear All Filters]
2016
Chauhan J, Cardinale S, Fang L, Huang J, Kwasny SM, M Pennington R, Basi K, diTargiani R, Capacio BR, Mackerell AD, et al. Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics. PLoS One. 2016 ;11(10):e0164515.
2014
Haidar JN, Zhu W, Lypowy J, Pierce BG, Bari A, Persaud K, Luna X, Snavely M, Ludwig D, Weng Z. Backbone flexibility of CDR3 and immune recognition of antigens. J Mol Biol. 2014 ;426(7):1583-99.
2012
Zhang F, Liang X, Pu D, George KI, Holland PJ, Walsh STR, Linhardt RJ. Biophysical characterization of glycosaminoglycan-IL-7 interactions using SPR. Biochimie. 2012 ;94(1):242-9.
Hawse WF, Champion MM, Joyce MV, Hellman LM, Hossain M, Ryan V, Pierce BG, Weng Z, Baker BM. Cutting edge: Evidence for a dynamically driven T cell signaling mechanism. J Immunol. 2012 ;188(12):5819-23.
Willis CD, Oashi T, Busby B, Mackerell AD, Bloch RJ. Hydrophobic residues in small ankyrin 1 participate in binding to obscurin. Mol Membr Biol. 2012 ;29(2):36-51.
2011
Wang XXiang, Li Y, Yin Y, Mo M, Wang Q, Gao W, Wang L, Mariuzza RA. Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4-HLA-DR1 complex. Proc Natl Acad Sci U S A. 2011 ;108(38):15960-5.
Busby B, Oashi T, Willis CD, Ackermann MA, Kontrogianni-Konstantopoulos A, Mackerell AD, Bloch RJ. Electrostatic interactions mediate binding of obscurin to small ankyrin 1: biochemical and molecular modeling studies. J Mol Biol. 2011 ;408(2):321-34.
Yin Y, Li Y, Kerzic MC, Martin R, Mariuzza RA. Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selection. EMBO J. 2011 ;30(6):1137-48.
Li Y, Wang Q, Mariuzza RA. Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6. J Exp Med. 2011 ;208(4):703-14.
2009
Dexheimer TS, Gediya LK, Stephen AG, Weidlich I, Antony S, Marchand C, Interthal H, Nicklaus M, Fisher RJ, Njar VCO, et al. 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors. J Med Chem. 2009 ;52(22):7122-31.
Luo H, Laksanalamai P, Robb FT. An exceptionally stable Group II chaperonin from the hyperthermophile Pyrococcus furiosus. Arch Biochem Biophys. 2009 ;486(1):12-8.
Schiel JE, Hage DS. Kinetic studies of biological interactions by affinity chromatography. J Sep Sci. 2009 ;32(10):1507-22.
Haidar JN, Pierce BG, Yu Y, Tong W, Li M, Weng Z. Structure-based design of a T-cell receptor leads to nearly 100-fold improvement in binding affinity for pepMHC. Proteins. 2009 ;74(4):948-60.
2008
Wang H, Walsh STR, Parthun MR. Expanded binding specificity of the human histone chaperone NASP. Nucleic Acids Res. 2008 ;36(18):5763-72.
2007
Deng L, Langley RJ, Brown PH, Xu G, Teng L, Wang Q, Gonzales MI, Callender GG, Nishimura MI, Topalian SL, et al. Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor. Nat Immunol. 2007 ;8(4):398-408.
2006
Fernández MM, De Marzi MC, Berguer P, Burzyn D, Langley RJ, Piazzon I, Mariuzza RA, Malchiodi EL. Binding of natural variants of staphylococcal superantigens SEG and SEI to TCR and MHC class II molecule. Mol Immunol. 2006 ;43(7):927-38.
Walsh STR, Kossiakoff AA. Crystal structure and site 1 binding energetics of human placental lactogen. J Mol Biol. 2006 ;358(3):773-84.
Silin VI, Karlik EA, Ridge KD, Vanderah DJ. Development of surface-based assays for transmembrane proteins: selective immobilization of functional CCR5, a G protein-coupled receptor. Anal Biochem. 2006 ;349(2):247-53.
2005
Kumar S, Roychowdhury A, Ember B, Wang Q, Guan R, Mariuzza RA, Boons G-J. Selective recognition of synthetic lysine and meso-diaminopimelic acid-type peptidoglycan fragments by human peptidoglycan recognition proteins I{alpha} and S. J Biol Chem. 2005 ;280(44):37005-12.
Li Y, Huang Y, Lue J, Quandt JA, Martin R, Mariuzza RA. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J. 2005 ;24(17):2968-79.
2004
Vanderah DJ, La H, Naff J, Silin VI, Rubinson KA. Control of protein adsorption: molecular level structural and spatial variables. J Am Chem Soc. 2004 ;126(42):13639-41.
2003
Yang J, Swaminathan CP, Huang Y, Guan R, Cho S, Kieke MC, Kranz DM, Mariuzza RA, Sundberg EJ. Dissecting cooperative and additive binding energetics in the affinity maturation pathway of a protein-protein interface. J Biol Chem. 2003 ;278(50):50412-21.
Walsh STR, Jevitts LM, Sylvester JE, Kossiakoff AA. Site2 binding energetics of the regulatory step of growth hormone-induced receptor homodimerization. Protein Sci. 2003 ;12(9):1960-70.
2002
Wang J, Whitman MC, Natarajan K, Tormo J, Mariuzza RA, Margulies DH. Binding of the natural killer cell inhibitory receptor Ly49A to its major histocompatibility complex class I ligand. Crucial contacts include both H-2Dd AND beta 2-microglobulin. J Biol Chem. 2002 ;277(2):1433-42.
N Rao M, Silin VI, Ridge KD, Woodward JT, Plant AL. Cell membrane hybrid bilayers containing the G-protein-coupled receptor CCR5. Anal Biochem. 2002 ;307(1):117-30.